PRVL - Citadel Advisors reports 7.0% stake in Prevail Therapeutics October, 09 2020 06:15 AM Prevail Therapeutics Inc. Citadel Advisors discloses a 7.0% ((~2.41M shares)) passive stake in Prevail Therapeutics (PRVL).Shares +6% premarket. SC-13G For further details see: Citadel Advisors reports 7.0% stake in Prevail Therapeutics